113.71 -0.46 (-0.40%)
Pre-market: 6:30AM EST
|Bid||114.18 x 900|
|Ask||114.25 x 800|
|Day's range||109.23 - 114.57|
|52-week range||28.00 - 131.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Moderna announces new expansion plans, and a study for its booster shot that targets the South African variant.
Executives from vaccine companies testified before House subcomittee on progress and hurdles in manufacturing vaccines.
It's the exact opposite of Murphy's law (the name is "Murphy" spelled backward). Pfizer (NYSE: PFE) seems to be experiencing the effects of Yhprum's law with the COVID-19 vaccine it developed and marketed with BioNTech (NASDAQ: BNTX). Pfizer and BioNTech have delivered nothing but good news for their COVID-19 vaccine Comirnaty (BNT162b2) so far.